Mortality in congestive heart failure: effects of vasodilator therapy.
作者信息
Timmis A D
机构信息
The London Chest Hospital.
出版信息
Br Med J (Clin Res Ed). 1987 Nov 14;295(6608):1225-6. doi: 10.1136/bmj.295.6608.1225.
Abstract
摘要
相似文献
1
Mortality in congestive heart failure: effects of vasodilator therapy.充血性心力衰竭的死亡率：血管扩张剂治疗的效果
Br Med J (Clin Res Ed). 1987 Nov 14;295(6608):1225-6. doi: 10.1136/bmj.295.6608.1225.
2
Role of vasodilator therapy in congestive heart failure. Effects on mortality.
Cardiol Clin. 1994 Feb;12(1):87-99.
3
Modern management of heart failure.
Br J Hosp Med. 1992;47(1):16-8, 20-2, 24.
4
[Drug therapy of heart failure].[心力衰竭的药物治疗]
Ther Umsch. 1993 Jun;50(6):425-33.
5
Progressive congestive heart failure. Ways to approach office management.进行性充血性心力衰竭。门诊管理方法。
Postgrad Med. 1991 May 1;89(6):102-7. doi: 10.1080/00325481.1991.11700920.
6
7
Potential for altering the natural history of congestive heart failure: need for large clinical trials.改变充血性心力衰竭自然病程的可能性：大型临床试验的必要性。
Am J Cardiol. 1985 Jan 11;55(2):45A-47A. doi: 10.1016/0002-9149(85)90796-9.
8
Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
Arch Intern Med. 1993 Feb 22;153(4):445-54.
9
[Digitalis, diuretic and vasodilator treatment of cardiac failure].[洋地黄、利尿剂和血管扩张剂治疗心力衰竭]
Rev Prat. 1997 Dec 1;47(19):2125-9.
10
Therapeutic interventions to reduce rates of hospitalization and death in patients with heart failure: new clinical evidence.降低心力衰竭患者住院率和死亡率的治疗干预措施：新的临床证据。
Cardiology. 1992;81(1):1-7. doi: 10.1159/000175769.
引用本文的文献
1
Effect of enalapril on mortality in congestive heart failure. Follow-up survival data from the CONSENSUS trial.依那普利对充血性心力衰竭死亡率的影响。来自CONSENSUS试验的随访生存数据。
Drugs. 1990;39 Suppl 4:49-52; discussion 53-4. doi: 10.2165/00003495-199000394-00010.
本文引用的文献
1
Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.肼屈嗪和硝酸异山梨酯：单独给药或联合给药时的中枢和局部血流动力学比较效应。
Circulation. 1981 Jan;63(1):102-9. doi: 10.1161/01.cir.63.1.102.
2
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Ann Intern Med. 1981 Jul;95(1):5-13. doi: 10.7326/0003-4819-95-1-5.
3
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).交感神经张力和肾素-血管紧张素系统对严重慢性充血性心力衰竭的作用：对特定抑制剂（哌唑嗪和卡托普利）的反应。
Am J Cardiol. 1982 May;49(7):1667-74. doi: 10.1016/0002-9149(82)90244-2.
4
Captopril in heart failure. A double blind controlled trial.卡托普利治疗心力衰竭。一项双盲对照试验。
Br Heart J. 1984 Nov;52(5):530-5. doi: 10.1136/hrt.52.5.530.
5
Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.长期使用卡托普利治疗重度慢性心力衰竭时的血流动力学反应模式。
Circulation. 1983 Oct;68(4):803-12. doi: 10.1161/01.cir.68.4.803.
6
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.卡托普利治疗慢性心力衰竭的对照试验：一项休息及运动时的血流动力学研究。
Circulation. 1983 Apr;67(4):807-16. doi: 10.1161/01.cir.67.4.807.
7
Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.重度慢性心力衰竭的血管扩张剂与正性肌力药物治疗：热情与质疑
J Am Coll Cardiol. 1983 Nov;2(5):841-52. doi: 10.1016/s0735-1097(83)80230-7.
8
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.肾素-血管紧张素系统在慢性心力衰竭中的临床重要性：卡托普利与哌唑嗪的双盲比较
Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1861-5. doi: 10.1136/bmj.290.6485.1861.
9
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.血管扩张剂疗法对慢性充血性心力衰竭死亡率的影响。退伍军人管理局合作研究的结果。
N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404.
10
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Circulation. 1986 Mar;73(3):492-502. doi: 10.1161/01.cir.73.3.492.
Zotero 插件